Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Leipzig |
---|---|
Information provided by: | University of Leipzig |
ClinicalTrials.gov Identifier: | NCT00402675 |
In non-ST-elevation the optimal time of percutaneous coronary intervention (PCI) is unclear.
Some studies showed benefit of very early PCI, some others early PCI between 12-48 hours and others even showed a benefit of a selective invasive approach only in case of recurrence of symptoms or a positive stress test.
The optimal timing of intervention is still matter of debate as a result of a randomized clinical trial.
Condition | Intervention | Phase |
---|---|---|
Myocardial Infarction |
Procedure: Timing of percutaneous coronary intervention |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Leipzig Immediate Versus Early and Late PercutaneouS Coronary Intervention triAl in NSTEMI - LIPSIA-NSTEMI TRIAL |
Estimated Enrollment: | 600 |
Study Start Date: | July 2006 |
In this randomized, controlled, open-label clinical trial we compare a very early cardiac catheterization (< 2,5 hours after randomization) similar to ST-elevation myocardial infarction treatment, versus an early invasive approach (within 2-48 hours after randomization) versus a selective invasive approach in patients with non-ST-elevation myocardial infarction.
All patients are treated with heparin, ASA, Clopidogrel loading dose (600 mg) with subsequent 75 mg/d and tirofiban for 24 hours.
Ages Eligible for Study: | 18 Years to 89 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Clinical symptoms:
Instable angina pectoris:
Troponin T:
Troponin T-elevation ≥ 0,03 μg/l
Exclusion Criteria:
Contact: Holger Thiele, MD, PhD | +493418651428 | thielh@medizin.uni-leipzig.de |
Germany | |
University of Leipzig - Heart Center | Recruiting |
Leipzig, Germany, 04289 |
Principal Investigator: | Holger Thiele | University of Leipzig |
Study ID Numbers: | Leipzig-4 |
Study First Received: | November 20, 2006 |
Last Updated: | November 21, 2006 |
ClinicalTrials.gov Identifier: | NCT00402675 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
NSTEMI infarction treatment percutaneous coronary intervention non-ST-elevation myocardial infarction |
Necrosis Heart Diseases Myocardial Ischemia Vascular Diseases |
Ischemia Infarction Myocardial Infarction |
Pathologic Processes Cardiovascular Diseases |